Prazosin is an effective antihypertensive while nonselective α adrenergic blockers are not because:
A. It is the only orally active α blocker
B. It improves plasma lipid profile
C. It does not concurrently enhance noradrenaline release
D. It improves urine flow in males with prostatic
hypertrophy
A. It is the only orally active α blocker
B. It improves plasma lipid profile
C. It does not concurrently enhance noradrenaline release
D. It improves urine flow in males with prostatic
hypertrophy